Two-thirds of associate veterinarians are paid on production — meaning their income depends on upselling procedures, creating a direct conflict with patient care

Approximately two out of three associate veterinarians in the United States are compensated on a production basis, typically earning 18% to 21% of the revenue they personally generate for the practice. In corporate-owned clinics, managers set revenue targets and track production metrics, and an associate who consistently falls below target faces reduced income, performance reviews, or termination. This compensation structure means that a veterinarian's paycheck goes up when they recommend more diagnostics, more procedures, and more follow-up visits — and goes down when they tell a pet owner 'let's wait and see' or 'this doesn't need treatment.' This is not a theoretical concern. It creates daily moral injury. A veterinarian examining a 14-year-old cat with early kidney disease faces a choice: recommend the conservative monitoring approach (which is medically reasonable but generates minimal revenue) or recommend a full diagnostic workup, prescription diet, and biweekly fluid therapy (which generates $2,000+ in revenue and may or may not improve the cat's quality of life). The production model incentivizes the second option. When veterinarians are forced to choose between their income and their medical judgment hundreds of times per year, the psychological toll is cumulative. Roughly half of all veterinarians report moderate to severe burnout, and moral distress — the anguish of being pressured to act against one's professional judgment — is identified as the top trigger for compassion fatigue in veterinary medicine. This structure persists because corporate consolidators and private equity firms need production-based pay to extract predictable returns from veterinary practices. A salaried veterinarian is a fixed cost; a production-paid veterinarian is a variable cost that scales with revenue. From a financial engineering standpoint, production pay is elegant. From a medical ethics standpoint, it is the same fee-for-service model that human medicine has spent decades trying to move away from. But veterinary medicine has no equivalent of value-based care, no quality metrics tied to outcomes, and no payer (like CMS or insurance companies) with leverage to demand the shift. The veterinarian bears the full moral weight of a system designed to maximize throughput.